The topic of the research paper is viz. the systematic study of the pharmaceutical industry of India which is threatened, due to the new controls brought by rules and regulations of the WTO region, especially regarding tariff policies, TRIPS (Trade Related Intellectual Property Rights), opening of Indian domestic market to foreign multinationals by adopting liberalization, maintenance of professional standards of business ethics, obtaining the world class quality approvals and accreditions for Indian pharmaceutical exports, adoption of 'product patents' in addition to 'process patents and restrictions on unauthorised imitations etc. Till 1995 Indian Pharmaceutical industry was governed by IPL (Indian Patent Laws) and laws controlling the production and distribution practices. After getting the membership of the World Trade Organization, which has become the apex international permanent body for reorganising and smoothening the World Trade and for bringing ideal International order in the global trade ethics by making the necessary controls mandatory on the part of the member countries, Indian Pharma industry is facing new difficulties and challenge
